This is a full-time 1 year MSc programme suitable for biomedical or life scientists who wish to acquire an extensive knowledge and key skills relating to the fundamental molecular and cellular regulation of immunity and its application to the treatment of disease. The programme will be delivered by world leaders at the forefront of immunology and immunotherapy research, each with an internationally renowned research group.
Over the past few years, significant advances have been made in the understanding of the molecular and cellular control of immune responses. These discoveries are now being translated into the design and testing of immunotherapeutic interventions for a range of diseases including cancer, autoimmunity and inflammatory disease. This programme is for biomedical or life scientists who wish to extend their knowledge and skills in both immunology and its translation to immunotherapy.
A series of interlinked taught modules cover molecular mechanisms in immune cell differentiation and function, autoimmunity, transplant and tumour immunology, and inflammation. This is complemented by comprehensive coverage of the latest developments in immunotherapy including the use of microbial products in immunomodulation and vaccination, small molecules and biologics, as well as cellular immunotherapy.
The programme aims to allow students to understand the research process, from the fundamental discoveries at the forefront of immunological research, to the application of novel interventional immune-based therapies.
A key part of the MSc programme is the planning, execution and reporting of a piece of independent study leading to submission of a dissertation. This study will be in the form of an extensive laboratory research project carried out in internationally renowned research groups. Each student will be a fully-integrated member of one of the large number of research teams in a wide variety of topics across both immunology and immunotherapy.
| Level | Masters |
| Discipline | Sciences |
| Duration | 12 months |
| Intakes | Jan, Sep |
| Application Fees | GBP 0 |
| Tuition Fees | GBP 28530 |
| Campus | Edgbaston |
| Language proficiency (minimum) | |
| IELTS | 6.5 |
|---|---|
| TOEFL | 88 |
| PTE | 67 |
| Duolingo | Not Accepted |
| Exam proficiency (minimum) | |
| SAT | Not Required / Waiver |
|---|---|
| ACT | Not Required / Waiver |
| GRE | Not Required / Waiver |
| GMAT | Not Required / Waiver |
Minimum GPA - 75.0%
91
108
503
--
QS Quacquarelli Symonds is the world’s leading provider of services, analytics, and insight to the global higher education sector, whose mission is to enable motivated people anywhere in the world to fulfil their potential through educational achievement, international mobility, and career development.
THE (Times Higher Education) has been providing trusted performance data on universities for students and their families, academics, university leaders, governments and industry, since 2004. We create university rankings to assess university performance on the global stage and to provide a resource for readers to understand the different missions and successes of higher education institutions.
The Academic Ranking of World Universities (ARWU) was first published in June 2003 by the Center for World-Class Universities (CWCU), Graduate School of Education (formerly the Institute of Higher Education) of Shanghai Jiao Tong University, China, and updated on an annual basis
The "Webometrics Ranking of World Universities" is an initiative of the Cybermetrics Lab, a research group belonging to the Consejo Superior de Investigaciones Científicas (CSIC), the largest public research body in Spain. CSIC is among the first basic research organizations in Europe. The CSIC consisted in 2006 of 126 centers and institutes distributed throughout Spain.
